Literature DB >> 24091743

Prognostic value of tumor-infiltrating mast cells in outcome of patients with esophagus squamous cell carcinoma.

Ashraf Fakhrjou1, Seid Mahdi Niroumand-Oscoei, Mohamad Hosein Somi, Morteza Ghojazadeh, Shahnaz Naghashi, Shabnam Samankan.   

Abstract

BACKGROUND: Squamous cell carcinoma (SCC) of the esophagus is one of the most common malignancies of the gastrointestinal tract and carries poor prognosis. The role of mast cell density (MCD) in the prognosis of most human tumors is partly known, and there is a growing body of studies addressing it. However, the prognostic value of MCD has not been investigated in esophageal SCC, and thus, it was the subject during this study.
METHODS: In this study, 78 patients with esophageal SCC in pT = 3 were selected, their MCD was evaluated with toluidine blue staining, and the relationship with survival rate was analyzed. Patients were compared in identical groups of lymph node involvement and post-surgery complementary therapy.
RESULTS: Survival rate was significantly decreased in patients with high MCD based on Kaplan-Meier analysis (P < 0.001). This relationship was also found in groups with similar lymph node involvement and post-surgery therapies.
CONCLUSIONS: The results of the current study showed that high MCD in the invasive edge of tumor is related to tumor progression and decreased survival rate following surgery.

Entities:  

Mesh:

Year:  2014        PMID: 24091743     DOI: 10.1007/s12029-013-9550-2

Source DB:  PubMed          Journal:  J Gastrointest Cancer


  43 in total

Review 1.  4. IgE, mast cells, basophils, and eosinophils.

Authors:  Calman Prussin; Dean D Metcalfe
Journal:  J Allergy Clin Immunol       Date:  2003-02       Impact factor: 10.793

2.  Mast cells have a protumorigenic role in human thyroid cancer.

Authors:  R M Melillo; V Guarino; E Avilla; M R Galdiero; F Liotti; N Prevete; F W Rossi; F Basolo; C Ugolini; A de Paulis; M Santoro; G Marone
Journal:  Oncogene       Date:  2010-08-23       Impact factor: 9.867

3.  Prognostic influence of tumor-infiltrating mast cells in patients with follicular lymphoma treated with rituximab and CHOP.

Authors:  Minna Taskinen; Marja-Liisa Karjalainen-Lindsberg; Sirpa Leppä
Journal:  Blood       Date:  2008-02-28       Impact factor: 22.113

4.  Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer.

Authors:  Tomas J Welsh; Ruth H Green; Donna Richardson; David A Waller; Kenneth J O'Byrne; Peter Bradding
Journal:  J Clin Oncol       Date:  2005-10-11       Impact factor: 44.544

5.  The prognostic relevance of angiogenesis and mast cells in squamous cell carcinoma of the oesophagus.

Authors:  G O Elpek; T Gelen; N H Aksoy; A Erdoğan; L Dertsiz; A Demircan; N Keleş
Journal:  J Clin Pathol       Date:  2001-12       Impact factor: 3.411

6.  Tumour angiogenesis and mast cell density in the prognostic assessment of colorectal carcinomas.

Authors:  M F Acikalin; U Oner; I Topçu; B Yaşar; H Kiper; E Colak
Journal:  Dig Liver Dis       Date:  2004-12-09       Impact factor: 4.088

7.  Mast cells are novel independent prognostic markers in prostate cancer and represent a target for therapy.

Authors:  Anna Johansson; Stina Rudolfsson; Peter Hammarsten; Sofia Halin; Kristian Pietras; Jonathan Jones; Pär Stattin; Lars Egevad; Torvald Granfors; Pernilla Wikström; Anders Bergh
Journal:  Am J Pathol       Date:  2010-07-08       Impact factor: 4.307

Review 8.  Mast cells and tumour angiogenesis: new insight from experimental carcinogenesis.

Authors:  Enrico Crivellato; Beatrice Nico; Domenico Ribatti
Journal:  Cancer Lett       Date:  2008-05-02       Impact factor: 8.679

9.  Trends in incidence of oesophageal and stomach cancer subtypes in Europe.

Authors:  Jessie Steevens; Anita A M Botterweck; Miranda J M Dirx; Piet A van den Brandt; Leo J Schouten
Journal:  Eur J Gastroenterol Hepatol       Date:  2010-06       Impact factor: 2.566

10.  Constitutive and inducible cytokine mRNA expression in the human mast cell line HMC-1.

Authors:  G Nilsson; V Svensson; K Nilsson
Journal:  Scand J Immunol       Date:  1995-07       Impact factor: 3.487

View more
  12 in total

1.  M6A regulator expression patterns predict the immune microenvironment and prognosis of non-small cell lung cancer.

Authors:  Xue Liu; Changsheng Ma; Hui Liu; Zhiqiang Sun; Judong Luo
Journal:  J Cancer Res Clin Oncol       Date:  2022-05-20       Impact factor: 4.322

Review 2.  Mast Cell-Targeted Strategies in Cancer Therapy.

Authors:  Michele Ammendola; Rosario Sacco; Giuseppe Sammarco; Maria Luposella; Rosa Patruno; Cosmo Damiano Gadaleta; Giovambattista De Sarro; Girolamo Ranieri
Journal:  Transfus Med Hemother       Date:  2016-03-09       Impact factor: 3.747

3.  The Role of Mast Cells in Molding the Tumor Microenvironment.

Authors:  A Rigoni; M P Colombo; C Pucillo
Journal:  Cancer Microenviron       Date:  2014-09-07

4.  Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.

Authors:  Wei Guo; Fengwei Tan; Qilin Huai; Zhen Wang; Fei Shao; Guochao Zhang; Zhenlin Yang; Renda Li; Qi Xue; Shugeng Gao; Jie He
Journal:  Front Immunol       Date:  2021-05-12       Impact factor: 7.561

Review 5.  Are Mast Cells MASTers in Cancer?

Authors:  Gilda Varricchi; Maria Rosaria Galdiero; Stefania Loffredo; Giancarlo Marone; Raffaella Iannone; Gianni Marone; Francescopaolo Granata
Journal:  Front Immunol       Date:  2017-04-12       Impact factor: 7.561

6.  Quantitative assessment of tumor-associated tissue eosinophilia and mast cells in tumor proper and lymph nodes of oral squamous cell carcinoma.

Authors:  Shivani Jain; Rashmi Gs Phulari; Rajendrasinh Rathore; Arpan K Shah; Sankalp Sancheti
Journal:  J Oral Maxillofac Pathol       Date:  2018 May-Aug

7.  Comprehensive Analysis of Tumor-Infiltrating Immune Cells and Relevant Therapeutic Strategy in Esophageal Cancer.

Authors:  Guangrong Lu; Liping Chen; Shengjie Wu; Yuao Feng; Tiesu Lin
Journal:  Dis Markers       Date:  2020-05-11       Impact factor: 3.434

8.  Immunoscore Signature Predicts Postoperative Survival and Adjuvant Chemotherapeutic Benefits in Esophageal Squamous Cell Carcinoma.

Authors:  Lingdun Zhuge; Binhao Huang; Juntao Xie; Zhendong Gao; Difan Zheng; Shanbo Zheng; Jiaqing Xiang; Jie Zhang
Journal:  Cancer Manag Res       Date:  2020-12-15       Impact factor: 3.989

9.  High infiltration of mast cells positive to tryptase predicts worse outcome following resection of colorectal liver metastases.

Authors:  Shinsuke Suzuki; Yasushi Ichikawa; Kazuya Nakagawa; Takafumi Kumamoto; Ryutaro Mori; Ryusei Matsuyama; Kazuhisa Takeda; Mitsuyoshi Ota; Kuniya Tanaka; Tomohiko Tamura; Itaru Endo
Journal:  BMC Cancer       Date:  2015-11-04       Impact factor: 4.430

10.  Identification of prognostic genes and tumor-infiltrating immune cells in the tumor microenvironment of esophageal squamous cell carcinoma and esophageal adenocarcinoma.

Authors:  Qilin Huai; Wei Guo; Liankui Han; Demiao Kong; Liang Zhao; Peng Song; Yue Peng; Shugeng Gao
Journal:  Transl Cancer Res       Date:  2021-04       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.